Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Patchy Bibasilar Lung Infiltrates/Effusions: Clinical Significance and Differential Diagnosis

Radiographic Interpretation

  • Patchy bibasilar infiltrates represent areas of increased density in the lower lung fields that may appear as irregular opacities on chest imaging, according to the Centers for Disease Control and Prevention (CDC) 1
  • The patchy distribution suggests an uneven or non-homogeneous process rather than a uniform consolidation, as noted in Intensive Care Medicine 3

Common Causes

Infectious Etiologies

  • Bacterial pneumonia often presents with patchy infiltrates that may be accompanied by parapneumonic effusions, as reported by the CDC 1, 4
  • Pneumocystis pneumonia (PCP) in immunocompromised patients can present with bilateral infiltrates, though typically more diffuse rather than patchy, according to the CDC 4

Inflammatory Conditions

  • Immune checkpoint inhibitor-related pneumonitis can present with patchy bilateral infiltrates and ground glass opacities, as described in the Journal for ImmunoTherapy of Cancer 5
  • Nonspecific interstitial pneumonia (NSIP) can show bilateral symmetric ground glass opacities or patchy consolidation, according to the American Thoracic Society 6

Cardiovascular Causes

  • Heart failure can lead to pulmonary edema with bibasilar infiltrates and effusions due to increased hydrostatic pressure, as noted in Intensive Care Medicine 3
  • Pulmonary veno-occlusive disease may present with interstitial infiltrates and pleural effusions, as reported in the European Heart Journal 8

Clinical Significance

  • The finding requires correlation with clinical symptoms such as cough, dyspnea, fever, or chest pain, as recommended by the CDC 3, 4
  • Physical examination may reveal bibasilar crackles, decreased breath sounds, or dullness to percussion over affected areas, according to the CDC 4
  • Further diagnostic testing should be guided by clinical presentation and may include complete blood count and inflammatory markers, as recommended by the CDC 4
  • Computed tomography (CT) may be used for better characterization of the infiltrates, as described in the Journal for ImmunoTherapy of Cancer 5
  • Consideration of bronchoscopy with bronchoalveolar lavage for microbiological and cytological evaluation in unclear cases, as noted in the Journal for ImmunoTherapy of Cancer 5